Skip to content
★ Sign in to follow
Fermenta Biotech logo

Fermenta Biotech Stock: price and insider trades · India

IN·Mcap ₹14B

Fermenta Biotech: what insiders have been doing

Every trade that managers of Fermenta Biotech disclose to SEBI (PIT + SAST) is tracked on this page. In the past year (8 November 2025 to 8 November 2026), 6 filings came from 4 insiders.

Only sales appear on the open market, 6 sales in all totalling €5.3M, filed by 4 insiders. No amount is published for 1 filing, which the totals therefore leave out. The largest single trade was a sale of €5.1M by Preeti Thakkar, published on 29 September 2026, equal to 4.1% of the market capitalisation.

Most trades are made public on the day they happen. That lag is the time during which only the insider knows about the trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.

With 6 filings in twelve months, the company is more active than the median of 4 filings across the 1,987 companies we follow on the same exchange. Since 2026, the database holds no purchases and 6 sales by insiders of the company.

This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.

Insider Decl.
6
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€5M
6 ops. · all time

Who traded when

BuySale
Sumesh Gandhi3 sales
Preeti Thakkar2 sales
Prashant Nagre1 sale

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 4,835 of 26,897 companies
68.3
score / 100
Value
61
Quality
76
FCF yld4.9%
Earn yld5.7%
EV/EBITDA10.8x
ROE·
Gross mgn60%
Net mgn14%
Debt/EBITDA0.9x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2026

FY ended March 2026 · cache

₹487.20
Analyst consensus
·
Income statement
Revenue₹5.2B
Gross profit₹3.1B60% margin
EBITDA₹1.3B24% margin
Net income₹717.7M11.7% margin
Valuation
PER (trailing)23.5x
P/Book3.4x
Beta-0.38
Balance sheet & cash
Market cap₹14B
Total debt₹1.1B
Free Cash Flow₹625M
Debt / Equity28%
Profitability & ownership
% insiders65.9%
% institutions0.0%
Last declaration on 30 September 2026
Declarations6 total
  • ▼
    PromoterExecutives
    0SEBI
    350,000 sharesEquity SharesSale of Shares - marketSEBI:315c0b9c1354f957f47779d1061853a59b42a89b
  • ▼
    PromoterExecutives
    553M INR30SEBI
    1,165,938 shares@ ₹474.604.13% mcap100.0% of flowEquityMarket SaleSEBI:9ec469f9b10633857ca81a32c8fb284fef7170ac
  • ▼
    KMPExecutives
    98,290 INR13SEBI
    200 shares@ ₹491.500.0007% mcap5.0% of flowEquityMarket SaleSEBI:850efae8916b37087c2e142c9c2fadf660ef877e
  • ▼
    KMPExecutives
    1M INR18SEBI
    2,100 shares@ ₹506.100.0076% mcap53.8% of flowEquityMarket SaleSEBI:f2a462e9c2f66a4a300b9b6df115f1a1e8080044
  • ▼
    KMPExecutives
    815,984 INR17SEBI
    1,600 shares@ ₹510.000.0058% mcap41.3% of flowEquityMarket SaleSEBI:1ad212760d68dc368bfa5267fe3ac2fa589794f8
  • ▼
    DirectorExecutives
    22M INR21SEBI
    44,000 shares@ ₹499.900.16% mcap100.0% of flowEquityMarket SaleSEBI:bd26f4dc22a50e0dd61fe84b1bc56d9afa658c53

6 of 6 declarations

About Fermenta Biotech

Fermenta Biotech is a biotechnology company focused on developing innovative solutions for the industry. It is listed on the XBOM.